ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ABVC ABVC BioPharma Inc

1.15
0.00 (0.00%)
プレマーケット
最終更新日: 17:09:29
15分遅延
名称 銘柄コード 市場 種別
ABVC BioPharma Inc ABVC NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 1.15 17:09:29
始値 安値 高値 終値 前日終値
1.15
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1822:25GLOBEAiBtl BioPharma Inc. Acquired TT Life Company, Valued at..
2024/4/1722:00GLOBEABVC BioPharma Executes a Global Licensing Definitive..
2024/4/1021:30GLOBEABVC BioPharma Executes a Global Licensing Term Sheet for..
2024/3/2621:30GLOBEABVC BioPharma Entered into a Global Licensing Deal of..
2024/3/2121:30GLOBEAiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging..
2024/3/1921:30GLOBEABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO..
2024/3/1422:30GLOBEABVC BioPharma Reports Annual 2023 Financials and Provides..
2024/3/0106:32EDGAR2Form 8-K/A - Current report: [Amend]
2024/3/0106:31EDGAR2Form 8-K/A - Current report: [Amend]
2024/2/2722:30GLOBEABVC's New Horizon for Oncology and Hematology Aims at..
2024/2/1707:04EDGAR2Form S-1/A - General form for registration of securities..
2024/2/1522:30GLOBEABVC BioPharma Executes a Definitive Agreement to Receive..
2024/2/1409:59EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1222:30GLOBEABVC BioPharma Receives Australian Patent, Valid Until 2040,..
2024/2/1007:04EDGAR2Form S-1/A - General form for registration of securities..
2024/2/0823:30EDGAR2Form 8-K - Current report
2024/2/0823:17GLOBEABVC Acquires $2.96 Million Worth of Land in Asia with..
2024/1/1807:01EDGAR2Form 8-K/A - Current report: [Amend]
2024/1/1807:00EDGAR2Form 8-K - Current report
2024/1/1806:30EDGAR2Form 8-K - Current report
2024/1/1307:01EDGAR2Form S-1 - General form for registration of securities under..
2024/1/0321:24GLOBEABVC BioPharma and its Subsidiary Receive $460M From AiBtl..
2023/12/0722:30GLOBEABVC BioPharma Announces Completion of Subject Treatment for..
2023/12/0522:30GLOBEABVC BioPharma Shares Insights from Dr. Scott Irwin of..
2023/11/2122:30GLOBEABVC BioPharma Receives U.S. Patent for ADHD Treatment, a..
2023/11/2022:30EDGAR2Form 8-K - Current report
2023/11/1807:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
2023/11/1807:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
2023/11/1700:05GLOBEABVC BioPharma Enters Definitive Agreement with Licensing..
2023/11/1623:20EDGAR2Form 8-K - Current report
2023/11/1523:00GLOBEABVC BioPharma Reports Third Quarter 2023 Financial and..
2023/11/1522:41EDGAR2Form 8-K - Current report
2023/11/1522:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/2621:30GLOBEABVC BioPharma Entered Into a Term Sheet to License Global..
2023/10/1721:30GLOBEABVC BioPharma Announces Completion of Subject Recruitment..
2023/10/0921:30GLOBEABVC BioPharma Receives Taiwanese Patent for Its Treatment..
2023/9/1322:01EDGAR2Form 8-K - Current report
2023/9/0621:30EDGAR2Form 8-K/A - Current report: [Amend]
2023/8/3121:30EDGAR2Form 8-K - Current report
2023/8/2321:30GLOBEABVC BioPharma Provides Updates on ADHD Phase IIb Clinical..
2023/8/1806:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
2023/8/1806:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
2023/8/1722:19GLOBEABVC Executes Cooperation Agreement for Strategic..
2023/8/1721:33EDGAR2Form 8-K - Current report
2023/8/1505:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1021:30GLOBEABVC BioPharma Regains Compliance With Nasdaq's Minimum Bid..
2023/8/1006:00EDGAR2Form 8-K/A - Current report: [Amend]
2023/8/0805:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/8/0721:30GLOBEABVC Corporate Update and CEO's Letter to Shareholders
2023/8/0721:00EDGAR2Form 8-K - Current report

最近閲覧した銘柄

Delayed Upgrade Clock